The trademark application MRESVIAV was filed by ModernaTX, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 7, 2023, and it was registered by office on February 14, 2024 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
Change of name and address of the trademark registration was recorded on May 14, 2024.